Although insulin \vas first identified as a hormone over 00 years ago, the molecular mechanism by whic*h it regulates intracellular processes is still not fully understood. T h e first step in insulin's action is its interaction with the a-subunit of the insulin receptor. which triggers activation of the protein tyrosine kinase associated with the receptor's psubunit I 1 1. Autophosphor~latioi~ of the p-subunit on tyrosine residues then converts it into an even more active protein kinase 121. but the next step is unclear. For this reason we have been trying to work 'backwards' to the receptor starting from one of the well established physiological actions of insulin.
Insulin stimulates the uptake of nutrients (glucose, amino acids, fatty acids) into cells and their conversion into storage macromolecules (glycogen. protein, tint) uithin minutes. and significant progress has been made recently in elucidating how insulin stimulates glycogen synthesis in mammalian skeletal muscle 131. An intravenous injection of insulin activates the protein serine/threonine kinase, termed insulin-stimulated protein kinase-l (ISI'K-1) which phosphorylates the regulatory subunit of the glycogen-associated form of protein phosphatase-l (I'I'l(;).
This activates PPI (;, increasing the rate at which it dephosphorylates and activates glycogen synthase. the rate-limiting enzyme in glycogen synthesis. Phosphorylation of the regulatory subunit also increases the rate at which PP1 C, dephosphorylates and inactivates phosphorylase kinase, explaining the inhibition of glycogenolysis by insulin. T h e activation of a protein phosphatase ( P P l G) by a protein kinase (ISPK-1) can also account for insulin's ability to increase the phosphorylation of some proteins and decrease the phosphorylation of others I 31. [4] . MAP kinase is the only known protein serirdthreonine kinase that is dependent on tyrosine phosphorylation for activity and it is also unique in requiring phosphorylation of a threonine as well as a tyrosine residue for activity 11 I ] . T h e phosphorylated threonine and tyrosine residues are located in the same tryptic peptide and separated by only one residue in a Thr-Glu-'I'yr sequence that is just N-terminal to the Ala-Pro-(;lu motif which is common t o all protein kinases I 12 1. it is not yet established that insulin activates MAPKK and MAP kinase in skeletal muscle, it seems likely that this will prove to be the case and that the pathways leading to the activation of MAP kinase by insulin in skeletal muscle, and by NGF and EGF in PC12 cells, are essentially identical (Fig. 1) . In order to elucidate this signal transduction pathway it is clearly now crucial to identify MAPKKK and its mechanism of activation. MAPKKK could be activated directly by phosphorylation catalysed by receptor protein tyrosine kinases, or indirectly through one or more intervening protein kinases that are activated by the receptor. Alternatively, the receptor protein tyrosine kinase may activate an enzyme responsible for generating a novel 'second messenger' which then activates MAPKKK (or a protein kinase upstream of it). One candidate for a second messenger is the inositol phospholipid. termed phosphatidylinositol 3,4,5-trisphosphate, whose levels increase rapidly in response to growth factors, such as insulin and NGF (reviewed in [20] ). The 85 kDa subunit of the enzyme which catalyses this reaction (phosphatidylinositol (PI) 3-kinase) contains src-homology-2 domains that allow it to interact with autophosphorylated growth factor receptors, an interaction that results in the activation of PI 3-kinase 1211.
MAP kinase that has been expressed in bacterial cells can self-phosphorylate on tyrosine and threonine residues upon incubation with Mg-ATP. Although this reaction is very slow in vitro, it has led to the suggestion that MAPKK may not be a protein kinase, but a protein that interacts with MAP kinase stimulating enormously the rate of autophosphorylation of the latter enzyme [22] . This idea has been excluded by using a mutant MAP kinase in which the lysine residue at the ATP-binding site was changed to arginine producing a protein devoid of kinase activity. This 'kinase inactive' mutant was phosphorylated by MAPKK from skeletal muscle at the same rate, to a similar extent, The reason why MAP kinase is activated by tyrosine phosphorylation is obscure since it clearly is not to provide a direct link to receptor protein tyrosine kinases (Fig. 1) . W e have suggested that activation by dual threonine and tyrosine phosphorylation is a 'failsafe' device to prevent MAP kinase from being activated even slightly by the myriad of other protein serine/threonine kinases and protein tyrosine kinases present in mammalian cells, ensuring that activation is only catalysed by MAPKK [ 161. However, this raises the question of what 'failsafe' device is employed to ensure that MAPKK is activated by MAPKKK(s) and no other enzyme. Although the inactivation of MAPKK by PP2A, but not protein tyrosine phosphatases, suggests it is activated by serinelthreonine (and not tyrosine) phosphorylation, an intriguing alternative possibility is suggested by the recent finding that PP2A (and PPl) are capable of dephosphorylating histidine residues on histone H4 that have been phosphorylated by a protein histidine kinase 1231. If MAPKKK were a protein histidine kinase, this would provide an excellent mechanism for ensuring that activation of MAPKK was only catalysed by MAPKKK.
